These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 11717374)

  • 1. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.
    Volkow ND; Chang L; Wang GJ; Fowler JS; Franceschi D; Sedler M; Gatley SJ; Miller E; Hitzemann R; Ding YS; Logan J
    J Neurosci; 2001 Dec; 21(23):9414-8. PubMed ID: 11717374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.
    Volkow ND; Chang L; Wang GJ; Fowler JS; Leonido-Yee M; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Logan J; Wong C; Miller EN
    Am J Psychiatry; 2001 Mar; 158(3):377-82. PubMed ID: 11229977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence.
    Wang GJ; Volkow ND; Chang L; Miller E; Sedler M; Hitzemann R; Zhu W; Logan J; Ma Y; Fowler JS
    Am J Psychiatry; 2004 Feb; 161(2):242-8. PubMed ID: 14754772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.
    Volkow ND; Wang GJ; Smith L; Fowler JS; Telang F; Logan J; Tomasi D
    Neuroimage; 2015 Nov; 121():20-8. PubMed ID: 26208874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased dopamine activity predicts relapse in methamphetamine abusers.
    Wang GJ; Smith L; Volkow ND; Telang F; Logan J; Tomasi D; Wong CT; Hoffman W; Jayne M; Alia-Klein N; Thanos P; Fowler JS
    Mol Psychiatry; 2012 Sep; 17(9):918-25. PubMed ID: 21747399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects.
    Yuan J; Liu XD; Han M; Lv RB; Wang YK; Zhang GM; Li Y
    Addict Biol; 2017 Jan; 22(1):229-234. PubMed ID: 26040446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
    McCann UD; Wong DF; Yokoi F; Villemagne V; Dannals RF; Ricaurte GA
    J Neurosci; 1998 Oct; 18(20):8417-22. PubMed ID: 9763484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Melega WP; Lacan G; Desalles AA; Phelps ME
    Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of neurokinin-1 receptor mediation of methamphetamine neurotoxicity in the striatum of the mouse brain.
    Yu J; Allison S; Ibrahim D; Cadet JL; Angulo JA
    Ann N Y Acad Sci; 2002 Jun; 965():247-53. PubMed ID: 12105100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.
    Johanson CE; Frey KA; Lundahl LH; Keenan P; Lockhart N; Roll J; Galloway GP; Koeppe RA; Kilbourn MR; Robbins T; Schuster CR
    Psychopharmacology (Berl); 2006 Apr; 185(3):327-38. PubMed ID: 16518646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
    Sekine Y; Iyo M; Ouchi Y; Matsunaga T; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Takei N; Mori N
    Am J Psychiatry; 2001 Aug; 158(8):1206-14. PubMed ID: 11481152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.
    Volkow ND; Wang G; Fowler JS; Logan J; Gerasimov M; Maynard L; Ding Y; Gatley SJ; Gifford A; Franceschi D
    J Neurosci; 2001 Jan; 21(2):RC121. PubMed ID: 11160455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers.
    Sekine Y; Ouchi Y; Takei N; Yoshikawa E; Nakamura K; Futatsubashi M; Okada H; Minabe Y; Suzuki K; Iwata Y; Tsuchiya KJ; Tsukada H; Iyo M; Mori N
    Arch Gen Psychiatry; 2006 Jan; 63(1):90-100. PubMed ID: 16389202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.
    Sekine Y; Minabe Y; Ouchi Y; Takei N; Iyo M; Nakamura K; Suzuki K; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Mori N
    Am J Psychiatry; 2003 Sep; 160(9):1699-701. PubMed ID: 12944350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
    Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE
    Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
    Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
    Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo.
    Wong DF; Harris JC; Naidu S; Yokoi F; Marenco S; Dannals RF; Ravert HT; Yaster M; Evans A; Rousset O; Bryan RN; Gjedde A; Kuhar MJ; Breese GR
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5539-43. PubMed ID: 8643611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
    Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization.
    Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
    Psychopharmacology (Berl); 2005 Jul; 180(3):501-12. PubMed ID: 15959831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.
    Scheffel U; Steinert C; Kim SE; Ehlers MD; Boja JW; Kuhar MJ
    Synapse; 1996 Jun; 23(2):61-9. PubMed ID: 8723710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.